| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 17, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
|
|||||||
Attachments
Disclaimer
Enveric Biosciences Inc. published this content on April 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 18, 2025 at 10:16 UTC.
